In non-small cell lung carcinoma (NSCLC) models, dual treatment with the thioredoxin reductase-1 (TXNRD1) antioxidant inhibitor auranofin and MK2206 induced cancer cell-specific apoptosis through ROS-stimulated JNK signaling (99). This evidence concerns the gene TXNRD1 and cancer.